These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 2529467)
1. An endogenous inhibitor of the protein tyrosine kinase activity of normal and malignant human lymphoid cells. Hall BS; Hoffbrand AV; Wickremasinghe RG Oncogene; 1989 Oct; 4(10):1225-31. PubMed ID: 2529467 [TBL] [Abstract][Full Text] [Related]
2. alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. Hu ZW; Shi XY; Lin RZ; Chen J; Hoffman BB J Pharmacol Exp Ther; 1999 Jul; 290(1):28-37. PubMed ID: 10381756 [TBL] [Abstract][Full Text] [Related]
3. Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. Michel F; Merle-Béral H; Legac E; Michel A; Debré P; Bismuth G J Immunol; 1993 Apr; 150(8 Pt 1):3624-33. PubMed ID: 8096854 [TBL] [Abstract][Full Text] [Related]
4. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts. Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826 [TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase modulation of protein kinase C activity regulates G protein-linked Ca2+ signaling in leukemic hematopoietic cells. Vichalkovski A; Kotevic I; Gebhardt N; Kaderli R; Porzig H Cell Calcium; 2006 Jun; 39(6):517-28. PubMed ID: 16620963 [TBL] [Abstract][Full Text] [Related]
6. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells. Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [TBL] [Abstract][Full Text] [Related]
8. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity. Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452 [TBL] [Abstract][Full Text] [Related]
9. Studies on bcl-2 protein in cultured lymphoid cells. Filip A; Rozynkowa D Cell Biol Int; 1994 Feb; 18(2):95-102. PubMed ID: 8019487 [TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor. Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the activity of protein kinases by endogenous heat stable protein inhibitors. Szmigielski A Pol J Pharmacol Pharm; 1985; 37(3):273-83. PubMed ID: 2999738 [TBL] [Abstract][Full Text] [Related]
12. Effect of quercetin on activities of protein kinase C and tyrosine protein kinase from HL-60 cells. Kang TB; Liang NC Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):374-6. PubMed ID: 10072927 [TBL] [Abstract][Full Text] [Related]
13. Two major tyrosine protein kinases of resting human T lymphocytes are down-regulated following mitotic stimulation. Hall BS; Hoffbrand AV; Wickremasinghe RG FEBS Lett; 1987 Oct; 223(1):6-10. PubMed ID: 3499351 [TBL] [Abstract][Full Text] [Related]
14. [Synthesis and biological activity of tyrosine protein kinase inhibitors]. Pang SH; Guo ZR; Liang XT Yao Xue Xue Bao; 1997 Jul; 32(7):515-23. PubMed ID: 11596277 [TBL] [Abstract][Full Text] [Related]
15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine protein kinase activity in normal and leukaemic human blood cells. Punt CJ; Rijksen G; Vlug AM; Dekker AW; Staal GE Br J Haematol; 1989 Sep; 73(1):51-6. PubMed ID: 2803978 [TBL] [Abstract][Full Text] [Related]
17. Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor. Fujita-Yamaguchi Y; Kathuria S Biochem Biophys Res Commun; 1988 Dec; 157(3):955-62. PubMed ID: 2974700 [TBL] [Abstract][Full Text] [Related]
18. Tyrosine protein kinases and their substrates in human leukemia cells. Wickremasinghe RG; Piga A; Mire AR; Taheri MR; Yaxley JC; Hoffbrand AV Leuk Res; 1985; 9(12):1443-50. PubMed ID: 4079454 [TBL] [Abstract][Full Text] [Related]